Locoregional recurrence in carcinoma of the ophthalmic sites: Primary cancer and secondary invasion from… | ScholarDeck

Paper

Locoregional recurrence in carcinoma of the ophthalmic sites: Primary cancer and secondary invasion from adjacent regions.

New research · Ophthalmology

Indian journal of ophthalmology · 1mo

Cohort studyIndian journal of ophthalmology· Jul 2026

Locoregional recurrence in carcinoma of the ophthalmic sites: Primary cancer and secondary invasion from adjacent regions.

Aniwat Berpan

Read paper

OculoplasticsCohort studyTreatmentQ2IF 1.6

Regional recurrence occurred in 17.6% of ophthalmic cancer patients after treatment

Locoregional recurrence in carcinoma of the ophthalmic sites: Primary cancer and secondary invasion from adjacent regions.

Aniwat Berpan

Indian journal of ophthalmology · Jul 2026 · Q2 in Ophthalmology

Background

To evaluate locoregional recurrence in patients treated with local treatment.

Methods

This was an institutional-based retrospective observational cohort study including 36 patients with ophthalmic plus nasal cavity (nasal cavity) and paranasal sinus carcinoma invading ophthalmic structures.

n = 36 patients

Results

17.6%

about 1 in 6 patients had cancer come back nearby after treatment

n = 36 patients

More results

Sebaceous carcinoma was found the most (35.3%), followed by squamous cell carcinoma (squamous cell carcinoma) (29.4%).

23.5% had nodal involvement, precisely within the parotid group.

All patients underwent surgery, including exenteration (n = 6).

Squamous cell carcinoma was found in 73.7%.

“

Conclusion

Patients requiring exenteration probably need postoperative radiotherapy to minimize local recurrence.

Read paper

0 comments

No comments yet. Be the first.

ScholarDeck.

Join the discussion on this paper

Create your profile

Related papers

Latest Foundational

AI / Informatics

0·962 for OCT

MerMED-FM was very accurate at diagnosing diseases using eye scans

Case Report

“Idiopathic retinal vasculitis, aneurysms, and neuroretinitis syndrome may be complicated by cilioretinal artery occlusion, resulting in poor final visual acuity despite reperfusion of the occluded artery.”

Review

20/20

normal vision achieved in one eye

Study

20/40

visual acuity was half of normal in both eyes

Cohort Study

7-year

adalimumab showed no new safety signals in this long-term extension

Cohort Study

25%

One-quarter of patients with head and neck sebaceous gland carcinoma had confirmed nodal metastasis.

Cohort Study

410°

wider field of binocular single vision after combined surgery

Guideline

“The increased incidence of postoperative complications should be taken into account when considering a surgical management.”